Legal Representation
Attorney
Peter Sloane
USPTO Deadlines 2 active 2 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OFFICE ACTION
Non-Final Action Mailed |
CNRT | Jun 24, 2025 | 13 days overdue | Critical | Until Sep 24, 2025 |
|
OFFICE ACTION
Non-Final Action E-Mailed |
GNRT | Jun 24, 2025 | 13 days overdue | Critical | Until Sep 24, 2025 |
Application History
11 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 25, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 6, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 6, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 6, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 6, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 6, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Aug 23, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Scientific laboratory services
First Use Anywhere:
Mar 1, 2024
First Use in Commerce:
Mar 1, 2024
Class 044
Medical laboratory analysis services relating to the treatment of persons
First Use Anywhere:
Mar 1, 2024
First Use in Commerce:
Mar 1, 2024
Additional Information
Design Mark
The mark consists of the letters OCC displayed three times and stacked on top of each other, where the letters alternate between blue and red, followed by the term OCCAM displayed in black on top of the word IMMUNE shown in gray and where both are justified to the right and the letter 'A' appears as the outline of an upward facing arrow.
Color Claim
The color(s) blue, red, black, gray is/are claimed as a feature of the mark.
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IMMUNE"